Inactive Instrument

News StemCells Inc Nasdaq

Equities

US85857R2040

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 16	HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating	MT
Mar. 27	Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating	Apr. 16	MT
Microbot Medical Shares Status Following Recent Geopolitical Events	Apr. 15	GL
Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Microbot Medical Submits US FDA Application to Start Human Clinical Trial for Robotic Surgical System	Feb. 05	MT
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US	Feb. 05	GL
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US	Feb. 05	CI
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters	Jan. 30	GL
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	Jan. 18	GL
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	Jan. 18	AQ
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	Jan. 18	CI
Sector Update: Health Care Stocks Ease Friday Afternoon	Dec. 29	MT
Microbot Medical to Exercise Outstanding Preferred Investment Options for $2.7 Million	Dec. 29	MT
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules	Dec. 29	GL
Sector Update: Health Care Stocks Rise in Late Afternoon	Dec. 28	MT
Microbot Medical Says GLP Preclinical Study of Liberty Endovascular Robotic Surgical System Met Objectives; Shares Rise	Dec. 28	MT
Sector Update: Health Care Stocks Advance Thursday Afternoon	Dec. 28	MT
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met	Dec. 28	GL
Microbot Medical Announces Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Met	Dec. 28	CI
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met	Dec. 28	AQ
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic	Dec. 14	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News StemCells Inc Nasdaq

Equities

US85857R2040

Summary

Filters